Hematopathology diagnostics

Hematological cancers vary significantly in both prognosis and aggressiveness, demonstrating a need for tools that assist pathologists in making confident diagnoses and helping to inform clinical decisions. We offer over 65 cornerstone and novel hematopathology ready-to-use reagents, including key IHC antibodies and ISH probes, that aid in the detection of lymphomas, leukemias and other hematopoietic malignancies.

The dynamic range of VENTANA OptiView DAB IHC detection delivers unparalleled sensitivity and specificity so you can detect antigens across a wide range of expression levels. Our hematopathology assays are optimized for use on the fully automated VENTANA BenchMark IHC/ISH series of instruments to maximize quality and laboratory efficiency.

bcl-2 (SP66) Rabbit Monoclonal Primary Antibody

VENTANA hematopathology suite of ready-to-use immunohistochemistry (IHC) and in situ hybridization (ISH) assays feature:

  • Exclusive assays such as the BRAF V600E (VE1) Mouse Monoclonal Primary Antibody
  • New products such as SOX-11 (MRQ-58) Mouse Monoclonal Primary Antibody, CD13 (SP187) Rabbit Monoclonal Primary Antibody and CD16 (SP175) Rabbit Monoclonal Primary Antibody
  • Choice of detection systems that allows visualization of antigens with low expression levels
CD30 (Ber-H2) Mouse Monoclonal Primary Antibody

We are excited to provide you with the reformulated CD30 (Ber-H2) Mouse Monoclonal Primary Antibody. A cornerstone tissue marker for lymphoma, CD30 delivers clinical confidence by aiding the pathologist in:

  • Diagnosis of T-cell and B-cell lymphomas
  • Identification of Reed-Sternberg cells in Hodgkins Lymphoma (HL)
  • Diagnosis of Anaplastic Large Cell Lymphoma (ALCL)

This reformulation features updated protocols for both OptiView DAB Detection and ultraView Universal DAB IHC Detection.


Virtual Slide Box Tour

Click here to learn more